secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLx Pharma Winddown Corp. (—)
CIK:        0001497504
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001193805-23-000963
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PLx Pharma Winddown terminates CEO and CFO amid Chapter 11 proceedings
----------------------------------------------------------------------

- Terminated CEO Natasha Giordano and CFO Rita O'Connor, effective June 30, 2023.
- CFO O'Connor entered consulting arrangement effective July 1, 2023.
- Board adopted bylaw amendment clarifying officer requirements on July 7, 2023.
- Company in Chapter 11 bankruptcy (Case No. 23-10456, District of Delaware).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000963/0001193805-23-000963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497504/000119380523000963/e618763_8k-plx.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer